Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration
Sign Up to like & getrecommendations! Published in 2019 at "Electromagnetic Biology and Medicine"
DOI: 10.1080/15368378.2019.1625784
Abstract: ABSTRACT Glioblastoma multiforme (GBM) is a highly malignant brain tumor with an extremely dismal prognosis, a median survival is12 months. Temozolomide (TMZ) is an alkylating agent widely used to treat cancer, resistance to this drug… read more here.
Keywords: 100 100; u87 cells; glioblastoma; glioblastoma u87 ... See more keywords